Magnolia Capital Management’s Pfizer PFE Stock Holding History

Magnolia Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,650	Closed	-$362K	–	74
2024 Q4	$362K	Hold	13,650	–	–	0.29%	61
2024 Q3	$395K	Hold	13,650	–	–	0.31%	60
2024 Q2	$382K	Hold	13,650	–	–	0.32%	58
2024 Q1	$379K	Hold	13,650	–	–	0.32%	56
2023 Q4	$393K	Hold	13,650	–	–	0.36%	52
2023 Q3	$453K	Hold	13,650	–	–	0.44%	46
2023 Q2	$501K	Sell	13,650 -3,550	-21%	-$138K	0.45%	47
2023 Q1	$702K	Hold	17,200	–	–	0.66%	32
2022 Q4	$881K	Hold	17,200	–	–	0.86%	28
2022 Q3	$753K	Hold	17,200	–	–	0.78%	27
2022 Q2	$902K	Hold	17,200	–	–	0.88%	26
2022 Q1	$890K	Hold	17,200	–	–	0.74%	29
2021 Q4	$1.02M	Hold	17,200	–	–	0.8%	28
2021 Q3	$740K	Buy	+17,200	New	+$762K	0.64%	34

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Magnolia Capital Management's PFE Position: Q1 2025 in Review

Magnolia Capital Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 13,650 shares — an estimated $362K sold.

Magnolia Capital Management first reported a position in PFE in Q3 2021 and held it in 14 quarters. The position peaked at $1.02M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Magnolia Capital Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Magnolia Capital Management sold 13,650 Pfizer shares in Q1 2025, an estimated $362K.
Magnolia Capital Management first reported a position in Pfizer in Q3 2021 and held it in 14 quarters.
Magnolia Capital Management's Pfizer position peaked at $1.02M in Q4 2021.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Magnolia Capital Management's 13F filing for Q1 2025, filed 3 Apr 2025.